Vergoeding 2019-2023 voor ATC-subgroep N03AX : Overige anti-epileptica
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| N03AX09 Lamotrigine (Lamictal ®) | 2.755.500 | 3.044.300 | 3.412.900 | 3.353.100 | 3.504.600 |
| N03AX10 Felbamaat (Taloxa ®) | 118.360 | 122.180 | 104.640 | 106.090 | 101.590 |
| N03AX11 Topiramaat (Topamax ®) | 1.297.500 | 1.432.000 | 1.445.600 | 1.509.500 | 1.736.700 |
| N03AX14 Levetiracetam (Keppra ®) | 5.189.500 | 6.777.200 | 7.081.600 | 7.352.200 | 8.027.800 |
| N03AX15 Zonisamide (Zonegran ®) | 367.090 | 371.920 | 366.790 | 381.070 | 377.430 |
| N03AX17 Stiripentol (Diacomit ®) | 423.970 | 410.120 | 420.200 | 466.660 | 463.720 |
| N03AX18 Lacosamide (Vimpat ®) | 4.920.400 | 5.479.500 | 5.517.700 | 6.385.500 | 6.045.400 |
| N03AX22 Perampanel (Fycompa ®) | 676.250 | 754.390 | 817.140 | 931.490 | 1.007.400 |
| N03AX23 Brivaracetam (Briviact ®) | 1.655.100 | 2.215.000 | 2.884.200 | 3.829.300 | 4.880.900 |
| N03AX24 Cannabidiol (Epidyolex ®) | . | . | . | 20.547 | 699.120 |
| N03AX25 Cenobamaat (Ontozry ®) | . | . | . | 71.749 | 570.120 |
| Totaal | 17.403.670 | 20.606.610 | 22.050.770 | 24.407.206 | 27.414.780 |